Form 4: Zimmer Biomet Executive Mark Bezjak Reports Stock Transactions

Mark Bezjak, President, Americas at Zimmer Biomet Holdings, Inc., reported the vesting of restricted stock units and subsequent stock transactions on March 6, 2024.

Summary

• On March 6, 2024, Mark Bezjak, President, Americas at Zimmer Biomet Holdings, Inc., reported transactions involving Zimmer Biomet common stock.
• Bezjak acquired 1,622 shares of common stock through the vesting of restricted stock units (RSUs).
• He then disposed of 395 shares to satisfy tax withholding obligations at a price of $125.82 per share.
• Following these transactions, Bezjak directly owns 4,358 shares of Zimmer Biomet common stock and 3,242 restricted stock units.
• One-third of the RSUs vested on March 6, 2024, with the remaining RSUs vesting in two equal installments on March 6, 2025, and March 6, 2026.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions, with no inherent positive or negative sentiment.

Future Outlook

The remaining RSUs will vest in two tranches on March 6, 2025, and March 6, 2026.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and aligns their interests with those of shareholders.

Stakeholder Impact

• The transactions have a minimal impact on shareholders, as they represent a small portion of the overall outstanding shares.

Key Dates